SHILO GIFFORD: Open Payments
NPI 1982988655 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,094 in 85 payments from 43 companies in 2025. Trend: 2023 $362 · 2024 $2,297 · 2025 $2,094
Food & beverage: $2,094
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $211 |
| PFIZER INC. | 7 | $155 |
| GlaxoSmithKline, LLC. | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Janssen Biotech, Inc. | 4 | $83 |
| Daiichi Sankyo Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $74 |
| Genentech USA, Inc. | 3 | $73 |
Products named: KEYTRUDA, OPDIVO, Enhertu, LIBTAYO, JEMPERLI, EPKINLY, Trodelvy, VERZENIO.
Industry payments across AZ — which companies pay providers there.
